Piramal Enterprises looking at acquisition of multiple pharma assets, possible re-entry into domestic formulations

Acquisitions of niche manufacturing capabilities for a Contract Development and Manufacturing Organisation, hospital generics business to sell specialised products in over 100 countries, and organic and inorganic addition of healthcare products among targets.